Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2025)
Historic Change in Acquisitions & Divestments for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $1.2 billion.
- Moderna's Change in Acquisitions & Divestments rose 881.29% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 65.31%. This contributed to the annual value of $5.6 billion for FY2024, which is 23.32% down from last year.
- According to the latest figures from Q3 2025, Moderna's Change in Acquisitions & Divestments is $1.2 billion, which was up 881.29% from $1.5 billion recorded in Q2 2025.
- Moderna's 5-year Change in Acquisitions & Divestments high stood at $2.0 billion for Q2 2024, and its period low was $277.0 million during Q3 2021.
- Over the past 5 years, Moderna's median Change in Acquisitions & Divestments value was $1.2 billion (recorded in 2025), while the average stood at $1.2 billion.
- In the last 5 years, Moderna's Change in Acquisitions & Divestments surged by 45120.97% in 2021 and then tumbled by 4385.03% in 2022.
- Moderna's Change in Acquisitions & Divestments (Quarter) stood at $1.1 billion in 2021, then crashed by 43.85% to $630.0 million in 2022, then skyrocketed by 37.14% to $864.0 million in 2023, then rose by 5.79% to $914.0 million in 2024, then skyrocketed by 32.39% to $1.2 billion in 2025.
- Its Change in Acquisitions & Divestments stands at $1.2 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.9 billion for Q1 2025.